Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.
| dc.contributor.author | Tural, Deniz | |
| dc.contributor.author | ŞENTÜRK ÖZTAŞ, Nihan | |
| dc.contributor.author | Sever, Ozlem Nuray | |
| dc.contributor.author | Ucar, Gokhan | |
| dc.contributor.author | Sendur, Mehmet Ali Nahit | |
| dc.contributor.author | Demirci, Umut | |
| dc.contributor.author | KILIÇKAP, SAADETTİN | |
| dc.contributor.author | ÇİÇİN, İRFAN | |
| dc.contributor.author | Oksuzoglu, Berna | |
| dc.contributor.author | Ozguroglu, Mustafa | |
| dc.contributor.author | ÜRÜN, YÜKSEL | |
| dc.contributor.author | Yekeduz, Emre | |
| dc.contributor.author | Erturk, Ismail | |
| dc.contributor.author | Karadurmus, Nuri | |
| dc.contributor.author | Karakaya, Serdar | |
| dc.contributor.author | Hizal, Mutlu | |
| dc.contributor.author | Arslan, Cagatay | |
| dc.contributor.author | Taban, Hakan | |
| dc.contributor.author | Kucukarda, Ahmet | |
| dc.date.accessioned | 2021-12-10T11:09:40Z | |
| dc.date.available | 2021-12-10T11:09:40Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Yekeduz E., Erturk I., Tural D., Karadurmus N., Karakaya S., Hizal M., Arslan C., Taban H., Kucukarda A., ŞENTÜRK ÖZTAŞ N., et al., "Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.", JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.6, 2021 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_6b7db6c8-da0a-4e7e-b1b8-d84ae8c4797a | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/171329 | |
| dc.identifier.uri | https://doi.org/10.1200/jco.2021.39.6_suppl.321 | |
| dc.language.iso | eng | |
| dc.subject | Oncology | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Health Sciences | |
| dc.title | Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database. | |
| dc.type | Makale | |
| dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
| dc.contributor.department | Ankara Üniversitesi , , | |
| dc.identifier.volume | 39 | |
| dc.identifier.issue | 6 | |
| dc.contributor.firstauthorID | 2615787 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Makale [92796]
